X-Message-Number: 18151
From: "John de Rivaz" <>
Subject: Biotime Inc
Date: Thu, 13 Dec 2001 09:47:31 -0000

A recent shareholders' circular from Biotime Inc, the spin - off from Trans
Time, appears at

http://www.streetlink.com/BTX/

The highlight is
>>>
Sales of Hextend  during the third quarter of 2001 increased to $971,472
from $669,409 in the previous quarter of the year. This represents a 45.1%
increase in sales, and was more than twice the 21.6% increase in Hextend
sales between the first and second quarters of this year, indicating
continued acceleration of sales growth. BioTime receives royalties
quarterly, based on sales of Hextend. This increase was highly significant
as it came during the summer quarter, when fewer elective surgeries are
generally performed. Sales were also temporarily impacted by the
postponement of many elective surgeries subsequent to the events of
September 11.
<<<

The spin-off is obviously highly advantageous to Trans Time.

--
Sincerely, John de Rivaz:      http://www.deRivaz.com
my homepage links to Longevity Report, Fractal Report, music, Inventors'
report, an autobio and various other projects:
http://www.geocities.com/longevityrpt
http://www.autopsychoice.com - http://www.cryonics-europe.org -
http://www.porthtowan.com

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=18151